VAM
Veritas Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208M | Sell |
863,141
-49,981
| -5% | -$12.1M | 2.08% | 15 |
|
|
2025
Q1 | $222M | Sell |
913,122
-63,705
| -7% | -$15.5M | 2.25% | 16 |
|
|
2024
Q4 | $321M | Sell |
976,827
-109,652
| -10% | -$36M | 2.99% | 16 |
|
|
2024
Q3 | $364M | Sell |
1,086,479
-42,332
| -4% | -$14.2M | 2.69% | 17 |
|
|
2024
Q2 | $308M | Sell |
1,128,811
-18,286
| -2% | -$4.99M | 2.33% | 18 |
|
|
2024
Q1 | $397M | Buy |
1,147,097
+64,202
| +6% | +$22.2M | 2.88% | 15 |
|
|
2023
Q4 | $350M | Sell |
1,082,895
-30,648
| -3% | -$9.9M | 2.52% | 16 |
|
|
2023
Q3 | $399M | Sell |
1,113,543
-23,906
| -2% | -$8.57M | 3% | 15 |
|
|
2023
Q2 | $431M | Sell |
1,137,449
-13,489
| -1% | -$5.11M | 3% | 15 |
|
|
2023
Q1 | $551M | Sell |
1,150,938
-1,349
| -0.1% | -$646K | 4.07% | 12 |
|
|
2022
Q4 | $485M | Buy |
1,152,287
+155,666
| +16% | +$65.5M | 3.97% | 14 |
|
|
2022
Q3 | $416M | Buy |
996,621
+229,859
| +30% | +$95.9M | 3.44% | 16 |
|
|
2022
Q2 | $380M | Buy |
+766,762
| New | +$380M | 2.83% | 16 |
|